Data positive for dual-optic lens
March 1st 2011While U.S. ophthalmologists continue to await FDA approval of the dual-optic accommodating IOL, accumulating data from a number of investigations are providing evidence about the long-term performance of this novel presbyopia-correcting implant technology.
Wavefront-guided, Wavefront-optimized LASIK: How much HOA?
March 1st 2011In young patients who present with low-to-moderate myopia, minimal astigmatism, and excellent optics, there is no doubt that wavefront-guided LASIK with femtosecond laser flap creation is the refractive surgery procedure of choice.
PBA supports USPSTF screening recommendation
March 1st 2011Prevent Blindness America (PBA) has commended the recent recommendation by the U.S. Preventive Services Task Force (USPSTF) for vision screening of all children aged 3 to 5 years. The USPSTF recommendation updates the task force?s 2004 recommendation of vision screening for all children aged fewer than 5 years. The USPSTF now recommends vision screening for the presence of amblyopia and its risk factors for all children aged 3 to 5 years.
Study: Haze a possibility for smokers
February 23rd 2011A line of photochromic performance sunwear (SOLFX, Transitions) debuted to more than 40,000 Professional Golfers' Association (PGA) of America and Ladies Professional Golf Association officials; retail and equipment buyers; golf course owners, managers, and developers; and golf instructors at the 2011 PGA Merchandise Show Jan. 26 to 29 in Orlando.
FDA approves generic levofloxacin
February 23rd 2011The FDA has granted final approval to Hi-Tech Pharmacal Co. Inc. for the company's abbreviated new drug application for levofloxacin ophthalmic solution 0.5%, the generic for a proprietary ophthalmic solution (Quixin, Vistakon). The product is indicated for bacterial conjunctivitis.